For the 1st time, FDA authorizes e-cigarettes
The Food and Drug Administration on Tuesday authorized e-cigarettes for the first time, saying data submitted by R.J. Reynolds indicates the company's Vuse digital vapor cigarette could help adults who are trying to quit or cut down on smoking.
This decision only applies to Vuse's refillable Solo Power devices and nicotine cartridges that are tobacco flavored. The FDA said R.J. Reynolds requested authorization of other flavored products, and those petitions were rejected. Last month, the FDA said it denied applications for more than 1 million e-cigarettes and associated products, primarily because they could appeal to minors, The Associated Press reports.
There haven't been many studies on how well e-cigarettes help smokers who are trying to quit, and companies have to show their products benefit public health in order to stay on the market. This first authorization is an "important step" toward "ensuring all new tobacco products undergo the FDA's robust, scientific premarket evaluation," Mitch Zeller, director of the FDA's tobacco center, said in a statement.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Five key changes from Rachel Reeves’ make-or-break budgetThe Explainer The chancellor is relying on a ‘smorgasbord’ of targeted revenue raisers to keep MPs, markets and voters onside
-
Prisoner 951: ‘illuminating’ Nazanin Zaghari-Ratcliffe dramaThe Week Recommends 'Harrowing' tale of prison ordeal and an ‘unbreakable’ bond between husband and wife
-
Sudoku medium: November 26, 2025The daily medium sudoku puzzle from The Week
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
